• Title/Summary/Keyword: 호르몬치료

Search Result 336, Processing Time 0.035 seconds

Effects and adverse-effects of growth hormone therapy in children with Prader-Willi syndrome: A two year study (Prader-Willi 증후군 소아에서 성장호르몬 치료의 효과와 부작용)

  • Kim, Su Jin;Cho, Joong Bum;Kwak, Min Jung;Paik, Kyung Hoon;Kwon, Eun Kyung;Jin, Dong-Kyu
    • Clinical and Experimental Pediatrics
    • /
    • v.51 no.7
    • /
    • pp.742-746
    • /
    • 2008
  • Purpose : The objective of this study was to evaluate the effects and adverse side-effects of growth hormone (GH) therapy in children with Prader-Willi syndrome (PWS). Methods : Forty-one patients who had been treated with GH for more than two years (24 boys and 17 girls, mean age $7.3{\pm}3.3$ years during treatment initiation) were enrolled for this study. Results : After 2 years of GH therapy, the height and weight standard deviation scores (SDS) increased significantly ($-1.19{\pm}1.37$ vs. $-0.02{\pm}1.45$, and $1.02{\pm}2.42$ vs. $1.63{\pm}2.22$, P<0.002); however the percentage body fat decreased ($44.6{\pm}9.9%$ vs. $38.1{\pm}10.5%$, P<0.001). Further, no change was observed in the thyroid and serum glucose levels, but the total cholesterol level decreased. GH therapy did not impact glucose control in the patients with diabetes. The most common adverse effects of GH therapy were the progression of scoliosis and adenoid hypertrophy. Conclusion : GH therapy improved the height SDS and body composition in patients with PWS. However, GH should be used with caution in patients with scoliosis and adenoid hypertrophy.

Vitamin C Enhances the Effect of Etoposide to Inhibit Human Prostate Cancer Growth in vitro (Vitamin C+etoposide 복합투여에 의한 전립선 암세포 성장 억제의 상승 효과)

  • Lee, Myeong-Seon
    • Applied Microscopy
    • /
    • v.38 no.3
    • /
    • pp.245-250
    • /
    • 2008
  • Etoposide (Eto) is chemotherapeutic compounds that is currently used in the treatment of metastatic prostate cancer but new therapeutic agents are needed for the treatment of androgen-independent prostate cancer. The objective of the present study was to determine whether vitamin C (VC), the antioxidant, plays a role in regulating the growth of prostate cancer cell lines and whether VC has synergistic effect to tumor cell killing by chemotherapeutic drugs. Androgen-dependent LNCaP and androgen-independent DU-145 prostate cancer cell lines were used in this study. Both cells presented increase of dose- and time-dependent cytotoxicity in Eto-treated cultures. The combined treatment with Eto and VC significantly increased the percentage of apoptotic cells compared to Eto-treated cells(p<0.05). The present findings demonstrated that VC inhibited the growth of prostate cancer cell lines by Eto-mediated cytotoxicity and induced apoptosis. These results suggest that the chemotherapeutic effect of Eto on prostate cancer can be enhanced by VC.

Phenomenological study about treatment experiences of Children with Precocious Puberty (성조숙증 치료경험 환아에 대한 현상학적 연구)

  • Kim, Young-Wha;Choi, Hye-Kyung;Gwak, Yun-Bock
    • Journal of Digital Convergence
    • /
    • v.16 no.7
    • /
    • pp.325-335
    • /
    • 2018
  • This study is a qualitative study applying phenomenological methodology to understand the experiences of childrens with precocious puberty and to describe the whole meaning. Participants were randomly selected from six childrens who had been diagnosed with precocious puberty. From October 12, 2016 to November 18, 2016, data were collected through in-depth interviews with individuals and group interviews. The method proposed by Colaizzi (1978) was used to guide the process of data analysis. Four theme clusters were derived from interview data : the treatment chosen by the mother, uncomfortable treatment, illness not understood well, and don't want to get treatment again. we identified the various emotional and psychological difficulties experienced by childrens with precocious puberty. Future research should develop a nursing intervention program to reduce the burden of the children and accept the treatment as a positive emotion.

Eosinophilic Pneumonia (호산구성 폐렴)

  • Son, Choonhee
    • Tuberculosis and Respiratory Diseases
    • /
    • v.64 no.3
    • /
    • pp.177-186
    • /
    • 2008
  • 호산구성 폐렴은 혈중 호산구가 $1,000/mm^3$ 이상이거나 폐포 내 호산구 분획이 25% 이상으로 나타나는 다양한 폐 질환을 총괄하여 부르는 용어이다. 혈중 호산구증가증은 특발성 급성 호산구 폐렴의 초기나 이미 부신피질호르몬 제제를 투여받은 환자에서는 나타나지 않을 수 있다. 호산구성 폐렴은 무증상의 폐 침윤에서 기계 환기가 필요한 급성 호흡 부전 증후군까지 증상의 중증도도 다양하다. 호산구성 폐렴의 원인으로 약제나 기생충이 있지만 많은 경우 원인을 찾을 수 없다. 폐 외 증상이 동반될 경우 Churg-Strauss 증후군이나 과다호산구증가 증후군의 가능성을 생가해야 되며 이런 경우 심장을 침범하였는지 여부에 따라 예후가 결정된다. 가능한 원인에 대한 노출을 피하는 것 외에는, 부신피질호르몬 제제 투여가 가장 중요하며 대부분 극적인 호전을 보인다. 하지만 약제의 감량 중이나 치료 종결 후 재발하는 경우가 자주 있다. HES의 골수 증식성 변이형 치료에 imatinib의 효과가 최근 입증 되었다.

Effects of growth hormone treatment on glucose metabolism in idiopathic short stature (특발성 저신장증 환자에서 성장 호르몬 투여가 당 대사에 미치는 영향)

  • Kwon, Seung Yeon;Kim, Duk-Hee;Kim, Ho-Seong
    • Clinical and Experimental Pediatrics
    • /
    • v.49 no.6
    • /
    • pp.665-671
    • /
    • 2006
  • Purpose : To study the effects of growth hormone(GH) treatment on glucose metabolism and insulin resistance in children with idiopathic short stature(ISS). Methods : Glucose and insulin concentrations were measured during oral glucose tolerance test (OGTT) before and after GH treatment(0.6-0.7 IU/kg/week) in 20 patients with ISS. Insulin resistance was assessed by homeostasis model assessment(HOMA). Results : During OGTT, the mean blood glucose level did not show any significant changes after GH treatment. However, mean blood insulin levels of fasting and 30 minutes of OGTT showed significant increases after GH treatment, accompanying significant increases of insulin resistance. There was no difference in change of glucose, insulin levels and insulin resistance before and after GH treatment between two groups of body mass indices(BMI) of 25< and >25. There also was no significant difference between two groups of with and without family histories of diabetes mellitus (DM). There was no case of newly developed impaired glucose tolerance, fasting glucose tolerance, nor newly developed DM. Conclusion : GH treatment with doses of 0.6-0.7 IU/kg/week for mean 9.6 months in patients with ISS did not show any significant changes in blood glucose levels during OGTT. However, GH treatments induced considerably higher fasting insulin levels compared to pretreatment, resulting in statistically higher insulin resistance. Higher BMI and family history of DM did not induce any significant changes in glucose, insulin level and insulin resistance after GH treatment than the other groups.

하절기 모돈의 무발정 원인과 대책

  • Jeon, Tae-Sik
    • The Korea Swine Journal
    • /
    • v.12 no.8 s.132
    • /
    • pp.128-131
    • /
    • 1990
  • 모돈의 미약발정은 발정징후를 나타내지만 수퇘지를 허용하지않으므로 종부를 시킬수 없다. 원인은 난포가 발달하지 못한 난포호르몬의 부족으로 인한 경우가 많은데, 치료는 PMS제제를 주로 사용하면 된다.

  • PDF

감염성 질병의 치료에 있어서 부신피질호르몬제 (corticosteroid)는 어떻게 이용돼야 하는가(I)

  • 이방환
    • Journal of the korean veterinary medical association
    • /
    • v.30 no.2
    • /
    • pp.67-74
    • /
    • 1994
  • 감염성 질병을 치료하는 데 있어서는 거의 모든 경우에 항생약제요법을 위주로 하고 여기에 여러 보조요법중의 하나로서 종종 corticosteroid요법이 첨가된다. 이 경우에 예상밖의 탁월한 효과를 거둔 경우가 있는가하면 반면에 오히려 치료효과를 지연시키거나 또는 예기치 못했던 부작용이나 속발증이 유발되어 수의사를 곤경에 빠뜨리는 경우가 종종 경험된다. 따라서 corticosteroid의 정체와 그 적절한 사용법을 분석$\cdot$검토해 볼 필요를 느끼게 된다.

  • PDF

국내 - NEWS&TOPICS

  • Ryu, Tong-Eun
    • The Science & Technology
    • /
    • no.5 s.444
    • /
    • pp.6-9
    • /
    • 2006
  • 13만kg 넘는 우유 생난 '슈퍼 젖소' / 제주남부 남해해역 3차원 영상물 제작/식약청, 55개 원료 내년부터 금지/ 10여종의 암 진단 칩 상용화 전망/ '한국 별' 8,9호/ 헬리코박터 특정 균종이 위암 유발/ 암 치료용 '유도미사일' 제조기술 개발/ 바이러스 유전자 조작 배터리 용량 늘려/ 면역 질환 사료 신물질 개발/ 세포에 인위적인 신호 보내 질병 치료/ 호르몬 작용 타이머 발견/ 뇌졸중 치료 메커니즘 규명/ 굶주림 신호 보내는 메커니즘 밝혀

  • PDF

A Case of Recovery of Ovarian Function in Woman Who was diagnosed as Premature Ovarian Failure (조기난소기능부전 환자 치험 1례)

  • Zhang, Kyung-Ho;Kim, Sang-Woo;Ko, Yu-Mi
    • The Journal of Korean Obstetrics and Gynecology
    • /
    • v.15 no.4
    • /
    • pp.193-201
    • /
    • 2002
  • Purpose : Premature ovarian failure, characterized by amenorrhea or oligomenorrhea, estrogen defieciency and elevated gonadotropins in woman less than 40 years of age, affects approximately 1% of woman and is associated with autoimmune phenomena or genetic abnormalities, but mostly idiopathic. This disease is loss of ovarian function seems not to be always permenent. Method : We investigated herb medication was effective in patient of premature ovarian failure. Results: Signs and symtoms of estrogen deficiency were improved and mensturation occurred monthly and the elevated during treatment of herb medication. As a result of our case recovering of ovarian function, we hope more investigtions about treating premature ovarian failure by oriental medicine will be gained.

  • PDF